Salmeterol/fluticasone propionate combination in the treatment of COPD. - Wikidata - awgldk - TriplyDB

Salmeterol/fluticasone propionate combination in the treatment of COPD.

Salmeterol/fluticasone propionate combination in the treatment of COPD.

http://www.wikidata.org/entity/Q37754942

about

Salmeterol/fluticasone propionate combination in the treatment of COPD.

http://www.wikidata.org/entity/Q37754942

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@en

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@nl

type

label

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@en

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@nl

prefLabel

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@en

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@nl

P1433

Q37754942-1BB72858-D859-4A5A-9396-5C24F012AC89

P1476

Q37754942-E7A0DEB1-FD6D-4372-960B-4C0F4D20B551

P2093

Q37754942-314ACD53-C966-4A90-94EB-49528D7861B1

P2860

Q37754942-083493A6-2D4A-4421-BBDF-C356F126CD6D

Q37754942-168638F3-7A27-45C2-A30A-49D9177EDE37

Q37754942-23D9B47C-6CA4-45FF-8B62-91B81DC8EE0E

Q37754942-287BF2B9-3B90-4929-A684-82794F3C22E8

Q37754942-29FA2080-F1CD-42DE-B5E1-835B135D1B90

Q37754942-2B164224-B46B-4ABD-B15D-9719F92751A8

Q37754942-30B4AB02-9DFF-424A-9FD1-97881A5F35BA

Q37754942-32F2B96E-51AD-4F5A-A060-3BE7380425EE

Q37754942-35FDF874-EDC0-4B0B-BA3C-689950BE264E

Q37754942-3A2BAD37-64BD-4564-9D2D-F0E9D7E78E98

P304

Q37754942-8E3E8808-E451-493F-9DBD-CBF5DD32E2F9

P31

Q37754942-B1817B63-7FA4-4C90-B9B7-28DB3C4B9976

P356

Q37754942-95F35C21-07E5-4DA1-885C-F3B4B3DF8215

P433

Q37754942-49A15F7C-20F0-4E0F-B332-732D3FE74082

P478

Q37754942-50D7117A-D52D-42AE-B554-569ED5985732

P577

Q37754942-3985EED7-D328-402A-8943-2A4D505E7B74

P698

Q37754942-50894ABC-E7B5-4CA4-B76D-A45B56197707

P356

17476348.1.1.25

P1433

Expert Review of Respiratory Medicine

P1476

Salmeterol/fluticasone propionate combination in the treatment of COPD.

@en

P2093

S Dave Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.

Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.

Epidemiology and costs of chronic obstructive pulmonary disease.

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.

P304

25-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17476348.1.1.25

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477262

http://www.w3.org/2001/XMLSchema#string